# FDA Inspection 1102699 - AptaPharma Inc. - September 25, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/aptapharma-inc/412628c1-3ed7-4ab7-afc9-0f5453b9d583/
Source feed: FDA_Inspections

> FDA Inspection 1102699 for AptaPharma Inc. on September 25, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102699
- Company Name: AptaPharma Inc.
- Inspection Date: 2019-09-25
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1231140 - 2024-10-24](https://www.globalkeysolutions.net/api/records/fda_inspections/aptapharma-inc/137899a3-a9c7-4739-8a69-df8e78f3e86c/)
- [FDA Inspection 1231140 - 2024-10-24](https://www.globalkeysolutions.net/api/records/fda_inspections/aptapharma-inc/6aa72e07-3da7-4980-8ab9-23ac21eb4f6f/)
- [FDA Inspection 1045668 - 2018-03-16](https://www.globalkeysolutions.net/api/records/fda_inspections/aptapharma-inc/56b08717-7de1-4c2d-9b87-592490ed7578/)
- [FDA Inspection 884304 - 2014-06-23](https://www.globalkeysolutions.net/api/records/fda_inspections/aptapharma-inc/05107648-0655-47e0-b223-f61ba95cd7cc/)

Company: https://www.globalkeysolutions.net/companies/aptapharma-inc/8390ea00-697d-4f5d-9e50-407830a6b2ee

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c